BURNS JAMES WILLIAM (Chief Legal Officer) sold 6.2% of their position (3.28K shares) of AGIOS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $113.8K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/6/2026ACC: 0001439222-26-000067
Officer· Chief Legal Officer
Since Jan 2022
-3.28K
Net shares
Net seller
$113.8K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
8.50K acquired · 11.78K disposed
Non-Derivative Transactions2
Common stock
Direct
Shares
+8.50K
Price / share
—
Trade value
—
% of position
19.3%
4/2/2026
44.09K→52.59K
Common stock
Direct
Shares
−3.28K
Price / share
$34.71
Trade value
$113.85K
% of position
6.2%
4/2/2026
52.59K→49.31K
Total
Net shares
+5.22K
Net value
-$113.85K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common stock Direct | 4/2/2026 | M · Option Exercise | +8.50K | — | — | 19.3% | 44.09K | 52.59K |
| Common stock Direct | 4/2/2026 | S · Sale | −3.28K | $34.71 | $113.85K | 6.2% | 52.59K | 49.31K |
| Total | +5.22K | -$113.85K | ||||||
Derivative Transactions1
Performance share units
Direct
Converts to
Common stock
8.50K shares
Shares
−8.50K
Strike price
Held after
8.50K
Exercisable
—
4/2/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Performance share units Direct | Common stock8.50K shares | 4/2/2026 | M · Option Exercise | −8.50K | — | 8.50K |